Phase 1 dose-escalation study of a novel oral PI3K/mTOR dual inhibitor, LY3023414, in patients with cancer
| Image |  |
|---|---|
| Description | scientific article published on 23 June 2020 |
| Author/s |
author: Shunsuke Kondo |
| Publication date | June 23, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |